Related Companies
|
[]
|
||||||||
Related Funds
|
[]
|
||||||||
|
|||||||||
English
|
|||||||||
oda_WinningATenderAbstract|
|
|
||||||||
oda_UpdateAnnouncementFlag|
|
|
Evet (Yes)
|
|||||||
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
04/07/2025
|
|||||||
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_AnnouncementContentSection|
|
|
||||||||
oda_SubjectOfTender|
|
|
Laboratory Service Procurement in Return for Results for Health Facilities Affiliated to our Directorate
|
|||||||
oda_PartyOpenedTender|
|
|
İstanbul İl Sağlık Müdürlüğü
|
|||||||
oda_BoardDecisionOnBidForTender|
|
|
04/07/2025 - 2025/18
|
|||||||
oda_OtherPartiesIfParticipatedInTheTenderAsAGroup|
|
|
Disera Tıbbi Malzeme Lojistik Sanayi ve Ticaret A.Ş.
|
|||||||
oda_ShareOfTheCompanyIfParticipatedInTheTenderAsAGroup|
|
|
51%
|
|||||||
oda_DateOfTenderBid|
|
|
04/07/2025
|
|||||||
oda_EndingUpDateOfTheTender|
|
|
15/08/2025
|
|||||||
oda_TenderResult|
|
|
The Tender has been awarded within the provisions of the Commission Decision.
|
|||||||
oda_TenderValue|
|
|
TRY 2,189,370,342.32
|
|||||||
oda_ShareOfCompanyInTenderValue|
|
|
TRY 1,116,578,874.58
|
|||||||
oda_RatioOfTenderValueCorporateShareAmountToGrossSalesRevenueOnPubliclyDisclosedTheLatestFinancialStatementOfCompany|
|
|
53,31%
|
|||||||
oda_ExplanationSection|
|
|
||||||||
oda_ExplanationTextBlock|
|
In our company's Special Situation Disclosure dated 04/07/2025, it was announced that our company, in partnership with Disera Tıbbi Malzeme Lojistik Sanayi ve Ticaret A.Ş., had participated in the tender titled "Laboratory Service Procurement against Results for Health Facilities Affiliated to our Directorate," with the tender TPN 2025/739894, to be conducted by the İstanbul İl Sağlık Müdürlüğü.
The bid amount submitted for the tender is TRY 2,189,370,342.32, and as of August 15, 2025 (today), we have been informed that the entire bid amount has been awarded to us. The services to be provided in relation to the tender in question will cover a period of 36 months starting from January 2026. Our company's share in the Joint Venture is 51%.
It is respectfully announced to the public. The English translation of this statement is attached here with and in case of any discrepancy in the texts of the statement, the Turkish statement will be taken as the basis. |